Nasal Decongestants

Drugs designed to treat inflammation of the nasal passages, generally the result of an infection (more often than not the common cold) or an allergy related condition, e.g., hay fever. The inflammation involves swelling of the mucous membrane that lines the nasal passages and results in inordinate mucus production. The primary class of nasal decongestants are vasoconstrictor agents. (From PharmAssist, The Family Guide to Health and Medicine, 1993)

Also Known As:

Decongestants; Vasoconstrictors, Nasal; Agents, Nasal Vasoconstrictor; Decongestant, Nasal; Decongestants, Nasal; Nasal Vasoconstrictor Agents; Nasal Vasoconstrictors; Decongestant; Nasal Decongestant; Vasoconstrictor Agents, Nasal

Chemical Actions and Uses
- Pharmacologic Actions: 164
  - Therapeutic Uses: 49043
    - Cardiovascular Agents: 832
      - Vasoconstrictor Agents: 4601
        Nasal Decongestants: 674
    - Respiratory System Agents: 150
      - Nasal Decongestants: 674

Saleh Alwasil Selected Research

Saleh Alwasil Research Topics

Disease

Drug/Important Bio-Agent (IBA)